References
- Hollingsworth RE, Jansen K. Turning the corner on therapeutic cancer vaccines. npj vaccines. NPJ Vaccines. 2019 Feb 08;4(1):7.
- Kjeldsen JW, Lorentzen CL, Martinenaite E, et al. A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma. Nat Med. 2021 Dec;27(12):2212–2223.
- Andersen MH. Novel understanding of self-reactive T cells. Oncoimmunology. 2016 Mar;5(3):e1083672.
- Sorensen RB, Hadrup SR, Svane IM, et al. Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators. Blood. 2011 Feb 17;117(7):2200–2210.
- McMaster M, Mohr K, Page A, et al. Epitope characterization of anti-drug antibodies-a tool for discovery and health: an overview of the necessity of early epitope characterization to avoid anti-drug antibodies and promote patient health. Expert Opin Biol Ther. 2021 Jun;21(6):705–715.
- Rossert J, Casadevall N, Eckardt K-U, et al. Anti-erythropoietin antibodies and pure red cell aplasia. J Am Soc Nephrol. 2004;15(2):398–406.
- Bassani-Sternberg M, Pletscher-Frankild S, Jensen LJ, et al. Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol Cell Proteomics. 2015 Mar;14(3):658–673.
- Pearson H, Daouda T, Granados DP, et al. MHC class I-associated peptides derive from selective regions of the human genome. J Clin Invest. 2016 Dec 1;126(12):4690–4701.
- Kedl RM, Kappler JW, Marrack P. Epitope dominance, competition and T cell affinity maturation. Curr Opin Immunol. 2003 Feb 01;15(1):120–127.
- Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov. 2007 May 1;6(5):404–414.
- Schwartzentruber DJ, Lawson DH, Richards JM, et al. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med. 2011;364(22):2119–2127.
- Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010 Aug 19;363(8):711–723.
- Rowlands DJ. How can peptide vaccines work? FEMS Microbiol Lett. 1992 Dec 15;100(1–3):479–481.